Comments*

 
  • Academy Events

  • Alzheimer's Disease as a Neurovascular Inflammatory Disorder

    Tuesday, December 6, 2016 | 9:00 AM - 5:00 PM
    The New York Academy of Sciences

    Presented by the Biochemical Pharmacology Discussion Group

      • Registration Closed

    Growing evidence supports a role for neurovascular inflammation as a major factor in Alzheimer's Disease (AD) onset and progression. However, the scientific community has yet to label AD a vascular disease and questions remain about the viability of neurovascular inflammation as a potential therapeutic target. This symposium will evaluate clinical and preclinical data, and discuss critical barriers to understanding how to clinically test vascular-based hypotheses for the treatment of AD.

    * Reception to follow.

    Registration Pricing

    Member $60
    Member (Student / Postdoc / Resident / Fellow) $25
    Nonmember (Academia) $105
    Nonmember (Corporate) $160
    Nonmember (Non-profit) $105
    Nonmember (Student / Postdoc / Resident / Fellow) $70

    This event will also be broadcast as a webinar; registration is required.

    Please note: Transmission of presentations via the webinar is subject to individual consent by the speakers. Therefore, we cannot guarantee that every speaker's presentation will be broadcast in full via the webinar. To access all speakers' presentations in full, we invite you to attend the live event in New York City where possible.

    Webinar Pricing

    Member $30
    Member (Student / Postdoc / Resident / Fellow) $15
    Nonmember (Academia) $65
    Nonmember (Corporate) $85
    Nonmember (Non-profit) $65
    Nonmember (Student / Postdoc / Resident / Fellow) $45


    The Biochemical Pharmacology Discussion Group is proudly supported by:

    • Boehringer Ingelheim
    • Regeneron

    American Chemical Society


    Premiere Supporter

    • Pfizer

    Grant Support

    Funding for this conference was made possible, in part, by R13NS098718 from the National Institute of Neurological Disorders and Stroke. Co-funding has been provided by the National Heart, Lung, and Blood Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official views of the National Institutes of Health; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    EmailPrint